NeuFluent develops neuroscience-based technologies, including dynamically controlled shunts and brain-computer interfaces, to enhance data interconnectivity and enable real-time monitoring of the central nervous system. Their solutions facilitate the adoption of new behaviors and learning processes, addressing the need for effective therapeutic interventions in neurological health.
Funding
Funding not disclosed
Founders
Product
Problem
Current neurological treatments often lack the precision and real-time monitoring capabilities needed for effective intervention and behavior modification. Existing methods may not adequately address the complex data interconnectivity within the central nervous system, hindering the adoption of new behaviors and learning processes.
Solution
NeuFluent develops advanced neuroscience-based technologies designed to enhance data interconnectivity and enable real-time monitoring of the central nervous system. Their dynamically controlled shunts and brain-computer interfaces aim to provide more effective therapeutic interventions for neurological health. By improving the brain's ability to process and respond to stimuli, NeuFluent's solutions facilitate the adoption of new behaviors and learning processes. The company collaborates with commercialization partners to accelerate the availability of these neurological products.
Target Audience
NeuFluent's primary customers include medical professionals, researchers, and commercialization partners focused on developing and implementing advanced neurological treatments.
Features
- Dynamically controlled shunts for precise regulation of fluid flow within the brain
- Brain-computer interfaces enabling direct communication between the brain and external devices
- Real-time monitoring capabilities for tracking central nervous system activity
- Technologies designed to enhance data interconnectivity within the brain